干细胞治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPHE100000991
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 206
Buy Now

干细胞治疗市场预计将从2022年的22.7849亿美元增长到2028年的62.0689亿美元;预计 2022 年至 2028 年间复合年增长率为 18.2%。

干细胞是初级身体细胞,所有其他具有特殊功能的细胞均由其产生。在体内或临床实验室的受控环境中,这些细胞分裂形成更多细胞,称为子细胞。随着现代健康科学的出现,这些细胞已被证明在了解疾病的发生、先进再生药物的产生以及其他药物的发现方面发挥着重要作用。干细胞在胚胎、骨髓、体脂肪和脐带血等中形成。

战略前景

市场前景

增加有机和主要参与者的无机战略

主要市场参与者正在采取各种有机和无机战略,包括并购、扩张和新产品发布,以保持市场竞争力。

  • 2022 年 10 月,Medipost(首席执行官 Won-Il Oh)宣布在韩国推出细胞和遗传治疗产品合同开发和制造组织 (CDMO) 业务。该公司宣布其新的 GMP 设施将拥有 10 个洁净室和生产设施,配备专门用于 CDMO 的更新设备。
  • 2019 年 12 月,Lineage Cell Therapeutics 和 AgeX Therapeutics 合作在美国注册了商标获得诱导多能干细胞生成方法专利。
  • 2021 年 6 月,Allogene Therapeutics, Inc. 宣布美国食品和药物管理局 (FDA) 授予该公司的下一代产品 ALLO-605 快速通道资格。新一代 AlloCAR T 疗法靶向 BCMA,用于治疗复发或难治性多发性骨髓瘤。 FDA 基于 ALLO-605 的潜力授予了快速通道资格,以解决其他多发性骨髓瘤标准疗法失败的患者未得到满足的需求。

因此,许多有机和无机策略细胞治疗市场使医疗保健专业人员能够提供更好的服务。

干细胞治疗市场利润丰厚的领域

干细胞治疗已在世界各地得到广泛研究。干细胞主要用于替代垂死细胞并重建受损组织。根据迄今为止进行的广泛干细胞研究的结果,许多科学家声称这些细胞可能用于治疗癌症和心血管疾病等疾病。新开发的干细胞疗法涉及用干细胞替代致病细胞。许多涉及干细胞的潜在治疗方法正处于临床试验的不同阶段。 FDA 还批准了一些涉及治疗干细胞移植相关并发症的干细胞疗法。 2021年9月,美国食品药品监督管理局(FDA)宣布批准“鲁索替尼”用于治疗12岁及以上患者的“移植物抗宿主病”(GVHD)。 Ruxolitinib 为患有与干细胞移植相关的危及生命的并发症的患者带来了新的希望。

研究人员正在进一步研究干细胞疗法在治疗自身免疫性疾病中的应用。例如,干细胞可以变成受损器官的细胞,并用于治疗自身免疫性疾病。使用间充质干细胞或胎儿干细胞进行治疗。造血干细胞目前用于治疗 80 多种疾病,包括免疫系统疾病;血液疾病;神经系统疾病;代谢紊乱;遗传性疾病;以及白血病和淋巴瘤等癌症类型。

类型见解

根据类型,干细胞治疗市场分为成体干细胞治疗、诱导多能干细胞治疗和干细胞治疗。胚胎干细胞疗法。细胞疗法和其他干细胞疗法。成体干细胞治疗领域在 2021 年占据最大的市场份额。然而,诱导多能干细胞治疗领域预计在预测期内(2022-2028 年)将创下最高复合年增长率。

治疗信息< /h3>

根据治疗方式,全球干细胞治疗市场分为同种异体和自体干细胞。 2021 年,同种异体细分市场占据最大的干细胞治疗市场份额。此外,自体细分市场预计在预测期内将以最高复合年增长率增长。

应用洞察

< p>从应用来看,干细胞治疗市场分为肌肉骨骼、皮肤病学、心脏病学、药物发现和开发以及其他应用。药物发现和开发领域在 2021 年占据最大的市场份额,预计在预测期内复合年增长率最高。

干细胞治疗市场(按类型):2021 年和 2028 年

最终用户观点

根据最终用户的观点,干细胞治疗市场分为学术市场和医疗市场。研究机构和医院诊所。学术与学术;研究机构细分市场在 2021 年占据了较高的市场份额,预计该细分市场在预测期内(2022-2028 年)的市场复合年增长率将更高。

干细胞治疗市场的公司主要采取并购等无机策略。下面列出了市场上最近的一些关键进展。

  • 2021 年 6 月,美国 FDA 授予下一代 ALLO-605 快速通道资格。 Allogene Therapeutics, Inc. 提供的 AlloCAR T 疗法以 BCMA 为靶点,用于治疗复发性或难治性多发性骨髓瘤。该指定的授予是基于 ALLO-605 具有解决对其他多发性骨髓瘤标准疗法无反应的患者未满足的需求的潜力。
  • 2021 年 6 月,MEDIPOST 宣布 La 公司扩大了生产设施其用于膝骨关节炎的干细胞产品 CARTISTEM 和 SMUP-IA-01,并将开始准备 GMP(良好生产规范)认证。
  • 2022 年 9 月,Caladrius Biosciences, Inc. 和 Cend Therapeutics, Inc. 宣布,经 Caladrius 批准后,两家公司的拟议合并已结束。股东大会将于 2022 年 9 月 13 日举行。合并后的公司将作为 Lisata Therapeutics, Inc. 运营,除了 Caladrius 的产品外,还将主要专注于在各种肿瘤适应症中推进其 CendR 平台技术候选产品。
  • 2019 年 3 月,BioTime, Inc 收购了专注于再生药物的 Asterias Biotherapeutics, Inc.,以巩固其干细胞疗法产品组合。
  • /ul>< h3 >公司简介
    • MEDIPOST
    • Pharmicell Co., Inc.
    • RichSource
    • BioTime , Inc.
    • >
    • Mesoblast Limited
    • Holostem Terapie Avanzate Srl
    • 美国干细胞公司
    • Caladrius Biosciences, Inc.
    • li>
    • TiGenix NV
    • AlloSource
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is meant by the stem cell therapy market?

Stem cells are preliminary body cells from which all other cells with specialized functions are generated. Under controlled environment in the body or a clinical laboratory, these cells divide to form more cells called daughter cells. Due to the advent of modern health science, these cells play a major role in understanding the occurrence of diseases, generation of advanced regenerative medicines, and drug discovery. There are certain sources such as embryo, bone marrow, body fats, and umbilical cord blood amongst others, where stem cells are generated.

What are the driving factors for the stem cell therapy market across the globe?

Increasing research activities related to stem cell therapy for effective disease management and growing prevalence of cancer are the most significant factors responsible for the overall market growth.

Which type segment led the stem cell therapy market?

Based on type segment, the adult stem cell therapy segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Which treatment segment held the largest market share in the stem cell therapy market?

Based on the treatment, allogenic segment took the forefront leaders in the worldwide market by accounting largest share in 2021.

Which end user segment held the largest market share in the stem cell therapy market?

Academic & Research institutes segment dominated the global stem cell therapy market and accounted for the largest market share during the forecast period of 2022-2028.

Who are the key players in the stem cell therapy market?

MEDIPOST, RichSource, BioTime, Inc., Mesoblast Limited, Holostem Terapie Avanzate Srl, U.S. Stem Cell, Inc., TiGenix NV, AlloSource, NuVasive Inc, JCR Pharmaceuticals Co. Ltd. and among others are among the leading companies operating in the stem cell therapy market.

What is the regional market scenario of the stem cell therapy market?

Global stem cell therapy market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.

The List of Companies - Stem Cell Therapy Market

  1. MEDIPOST
  2. RichSource
  3. BioTime, Inc.
  4. Mesoblast Limited
  5. Holostem Terapie Avanzate Srl
  6. U.S. Stem Cell, Inc.
  7. TiGenix NV
  8. AlloSource
  9. NuVasive Inc
  10. JCR Pharmaceuticals Co. Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports